Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
November 1, 2023Cardiology in Review

FlowTriever System for Pulmonary Embolism: A Review of Clinical Evidence

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Thrombolytic treatments for pulmonary embolism carry an increased bleeding risk, prompting the need for mechanical thrombectomy devices like the FlowTriever System that resolve vascular occlusion without thrombolytics.

Is the FlowTriever System safe and effective for treating intermediate-risk and high-risk pulmonary embolism?

Population

Patients with intermediate-risk and high-risk PE, and various large vessel thromboses

Comparison

FlowTriever System mechanical thrombectomy

Design

Clinical evidence review

Authors

DWDavid Haner WassersteinWFWilliam H. Frishman

Discussion

Loading...

Member takes

Overview

FlowTriever appears safe and effective for intermediate- and high-risk PE; leaves open need for randomized comparisons versus thrombolysis.

Structured PICO

Is the FlowTriever System safe and effective for treating intermediate-risk and high-risk pulmonary embolism?

P
Population
Patients with intermediate-risk and high-risk pulmonary embolism (PE), and various large vessel thromboses
I
Intervention
FlowTriever System (mechanical thrombectomy device)
O
Outcome
Safety and effectiveness in treating intermediate-risk and high-risk PE

The FlowTriever System offers a safe and effective mechanical thrombectomy option for intermediate and high-risk pulmonary embolism, avoiding the bleeding risks associated with thrombolytics.

Cite This Study

Wasserstein et al. (2023) studied this question.

synapsesocial.com/papers/6a6fe0bce71d69abee084010https://doi.org/10.1097/crd.0000000000000605
View Full Paper
Ask AI
Bookmark
Share